Management of hepatic encephalopathy

Area of Science:

• Hepatology and critical care medicine
• Neurology and internal medicine

Background:

• Hepatic encephalopathy (HE) management is complex and depends on liver failure acuity.
• Critical steps include stabilization, addressing precipitating factors, ammonia reduction, intracranial pressure (ICP) management, and treating complications like hyponatremia.
• Liver failure patients are susceptible to various medical issues exacerbating HE, necessitating thorough patient evaluation.

Purpose of the Study:

• To outline critical management steps for hepatic encephalopathy in acute and chronic liver failure.
• To highlight specific considerations for acute liver failure, including etiology identification and ICP management.
• To discuss established and emerging therapies for chronic hepatic encephalopathy.

Main Methods:

• Review of critical management steps for hepatic encephalopathy.
• Discussion of diagnostic considerations, including brain imaging for focal deficits.
• Overview of therapeutic strategies for both acute and chronic liver failure patients.

Main Results:

• Five critical management steps are universal: stabilization, addressing precipitating factors, lowering blood ammonia, managing ICP, and treating complications.
• In acute liver failure, identifying the cause (e.g., acetaminophen poisoning) and managing ICP are paramount.
• Lactulose and rifaximin are mainstays for chronic HE, alongside identifying and reversing precipitating causes.

Conclusions:

• Comprehensive management of hepatic encephalopathy involves a multi-faceted approach tailored to liver failure acuity.
• Liver transplantation is the definitive treatment for acute liver failure with HE.
• Ongoing research aims to develop novel pharmacologic and interventional therapies for HE.